Vancomycin Hydrochloride (Page 4 of 4)

17 PATIENT COUNSELING INFORMATION

Severe Dermatologic Reactions

Advise patients about the signs and symptoms of serious skin manifestations. Instruct patients to stop taking Vancomycin Hydrochloride Capsules immediately and promptly seek medical attention at the first signs or symptoms of skin rash, mucosal lesions or blisters [see Warnings and Precautions (5.5)].

Antibacterial Resistance

Patients should be counseled that antibacterial drugs including Vancomycin Hydrochloride Capsules should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Vancomycin Hydrochloride Capsules are prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Vancomycin Hydrochloride Capsules or other antibacterial drugs in the future.

Manufactured by:
ANI Pharmaceuticals, Inc.
Baudette, MN 56623

Package/Label Display Panel

NDC 62559-390-20
Vancomycin Hydrochloride Capsules USP
125 mg*
Rx only
Not a Child Resistant Container
20 Capsules

(click image for full-size original)

Package/Label Display Panel

NDC 62559-391-20
Vancomycin Hydrochloride Capsules USP
250 mg*
Rx only
Not a Child Resistant Container
20 Capsules

(click image for full-size original)

Revised: 01/2022 ANI Pharmaceuticals, Inc.